Announcements Trials
Browse Landscape

Phase

Phase 1/2 2

Status

Completed 11Unknown 2Terminated 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 41Lymphoid 10Other hematologic neoplasm 6Thoracic 2Gastrointestinal 2CNS 2Other solid neoplasm 1Gynecologic 1Genitourinary 1

Conditions

Glioblastoma 2Recurrence 1Rectal Neoplasms 1Pancreatic Neoplasms 1Multiple Myeloma 1Liver Neoplasms 1Gallbladder Neoplasms 1Colonic Neoplasms 1

Interventions

Temozolomide 66Radiotherapy 52Carboplatin 25Bevacizumab 21Cisplatin 19Radiosurgery 18Vincristine 17Etoposide 17Cyclophosphamide 17Surgical Procedures, Operative 13Magnetic Resonance Spectroscopy 13Chemotherapy, Adjuvant 11Melphalan 10Lomustine 10Drug Therapy 10Filgrastim 9Erlotinib Hydrochloride 9apatinib 8Pemetrexed 83-Iodobenzylguanidine 8anlotinib 7Radiation 7Peripheral Blood Stem Cell Transplantation 7Methotrexate 7Thiotepa 6Isotretinoin 6Irinotecan 6Ifosfamide 6Doxorubicin 6Carmustine 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Bortezomib × CNS × Clear all
NCT03643549 2024-02-29

BORTEM-17

Haukeland University Hospital

Phase 1/2 Unknown
63 enrolled
CNS

Glioblastoma, Recurrence

NCT03607643 2018-07-31

A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI Malignancies

Leaf Vertical Inc.

Phase 1/2 Unknown
160 enrolled
CNSGastrointestinalPlasma cell

Colonic Neoplasms, Gallbladder Neoplasms, Glioblastoma, Liver Neoplasms, Multiple Myeloma, Pancreatic Neoplasms, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡